Androgen-Independent Prostatic Cancer (1)

Androgen-Independent Prostatic Neoplasms (1)

Androgen-Insensitive Prostatic Cance (1)

Androgen-Resistant Prostatic Cancer (1)

Hormone Refractory Prostatic Cancer (1)

Immune Checkpoint Inhibitor (1)

Immunotherapy (1)

Inhibitory Checkpoint Molecule (1)

Prostate Cancer Recurrent (1)

Not yet recruiting (1)

phase 2 (1)

MacroGenics (1)

docetaxel (1)

lorigerlimab (1)

prednisone (1)

biological (1)

drug (1)

Industry (1)

Interventional (1)

inhibitory checkpoint molecule

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

May 4, 2023